Ultragenyx Pharmaceutical Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-466M
Free Cash Flow
$-472M
Investing Cash Flow
$236M
Financing Cash Flow
$478M
Capex
$6M
Acquisitions
$0
Stock-Based Comp
—
D&A
$35M
SBC Allocated Expense
$153M